About SCIEX
SCIEX is a company based in Boston (United States) founded in 1970 was acquired by Danaher in September 2009. SCIEX has completed 1 acquisition, including Intabio. SCIEX operates in a competitive market with competitors including Cepheid, Helix, Beckman Coulter, Bruker and Benchling, among others.
- Headquarter Boston, United States
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Sciex India Private Limited
- Date of Incorporation 14 Mar, 2023
- Jurisdiction Mumbai, Maharashtra, India
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
People of SCIEX
Unlock access to complete
Software Development Team
49 people
Sales and Marketing
47 people
Senior Team
29 people
Leadership Team
25 people
Human Resources and Administration
22 people
Finance and Accounting
19 people
Product Management Team
15 people
Sr. Team
9 people
Unlock access to complete
Funding Insights of SCIEX
Investors in SCIEX
SCIEX has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include Danaher and European Union.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
|
Locked | Locked | Locked | |
|
Dental equipment and medical instruments are manufactured for therapeutic areas.
|
Locked | Locked | Locked |
Investor details for SCIEX
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by SCIEX
SCIEX has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Intabio.
Investment portfolio details for SCIEX
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Analytical platform for biotherapeutic drug quality characterization is offered.
|
Locked | Locked | 2015 | Locked |
Complete acquisition details for SCIEX
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - SCIEX
Detailed financials for SCIEX
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Sciex Comparisons
Peer comparison for SCIEX
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of SCIEX
SCIEX operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Cepheid, Helix, Beckman Coulter, Bruker and Benchling, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Developer of molecular diagnostic testing solutions
|
|
| Locked | Locked | Locked |
Genomic database for clinical research is provided.
|
|
| Locked | Locked | Locked |
Provider of products for biomedical testing for R&D, diagnostic and commercial applications
|
|
| Locked | Locked | Locked |
Diversified research instrument systems are manufactured and supplied.
|
|
| Locked | Locked | Locked |
Cloud-based bioinformatics platform is offered for biotech research.
|
|
| Locked | Locked | Locked |
Medical devices for neurological therapies are developed.
|
Detailed competitors of SCIEX
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Sciex
Complete news archive for SCIEX
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about SCIEX
SCIEX was founded in 1970 and raised its 1st funding round 44 years after it was founded.
SCIEX is headquartered in Boston, United States. It is registered at Boston, Massachusetts, United States.
SCIEX was established in 1970 and is headquartered in Boston, United States. Focus is placed on the life science sector, where scientific instrumentation, software, and related services are supplied. Key products encompass mass spectrometers, electrophoresis instruments, and front-end HPLC MS systems. Consumables, reagents, and kits are also distributed to support research and analytical processes in the industry.
SCIEX's top competitors include Cepheid, Helix and Blackrock Neurotech.
SCIEX has made 1 acquisition, including Intabio.
SCIEX has 2 investors. Key investors include Danaher, and European Union.